Search

Search Constraints

You searched for: Author/Creator Curran, A

Search Results

7. Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort2. Issue 3 (27th January 2019)

8. Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir. Issue 6 (12th January 2014)

10. Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. Issue 6 (9th January 2013)